EAM
AMGN icon

Exome Asset Management’s Amgen AMGN Stock Holding History

Exome Asset Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-6,700
Closed -$2.16M – 64
2024
Q3 		$2.16M Sell
6,700
-5,100
-43% -$1.67M 1.46% 33
2024
Q2 		$3.69M Buy
+11,800
New +$3.47M 3.28% 8

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Exome Asset Management's AMGN Position: Q4 2024 in Review

Exome Asset Management sold out of Amgen (AMGN) in Q4 2024, closing a stake of 6,700 shares — an estimated $2.16M sold.

Exome Asset Management first reported a position in AMGN in Q2 2024 and held it in 2 quarters. The position peaked at $3.69M in Q2 2024. 2,855 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.

  • Exome Asset Management reported no remaining Amgen position as of Q4 2024 after selling out during the quarter.
  • Exome Asset Management sold 6,700 Amgen shares in Q4 2024, an estimated $2.16M.
  • Exome Asset Management first reported a position in Amgen in Q2 2024 and held it in 2 quarters.
  • Exome Asset Management's Amgen position peaked at $3.69M in Q2 2024.
  • 2,855 funds tracked by Wall St. Rank held Amgen as of Q4 2024.

Based on Exome Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.